180 related articles for article (PubMed ID: 26900700)
21. Aspects of liver pathology in adult patients with MDR3/ABCB4 gene mutations.
Wendum D; Barbu V; Rosmorduc O; Arrivé L; Fléjou JF; Poupon R
Virchows Arch; 2012 Mar; 460(3):291-8. PubMed ID: 22331132
[TBL] [Abstract][Full Text] [Related]
22. A functional classification of ABCB4 variations causing progressive familial intrahepatic cholestasis type 3.
Delaunay JL; Durand-Schneider AM; Dossier C; Falguières T; Gautherot J; Davit-Spraul A; Aït-Slimane T; Housset C; Jacquemin E; Maurice M
Hepatology; 2016 May; 63(5):1620-31. PubMed ID: 26474921
[TBL] [Abstract][Full Text] [Related]
23. 4-phenylbutyrate enhances the cell surface expression and the transport capacity of wild-type and mutated bile salt export pumps.
Hayashi H; Sugiyama Y
Hepatology; 2007 Jun; 45(6):1506-16. PubMed ID: 17538928
[TBL] [Abstract][Full Text] [Related]
24. Effect of CFTR correctors on the traffic and the function of intracellularly retained ABCB4 variants.
Ben Saad A; Vauthier V; Tóth Á; Janaszkiewicz A; Durand-Schneider AM; Bruneau A; Delaunay JL; Lapalus M; Mareux E; Garcin I; Gonzales E; Housset C; Aït-Slimane T; Jacquemin E; Di Meo F; Falguières T
Liver Int; 2021 Jun; 41(6):1344-1357. PubMed ID: 33650203
[TBL] [Abstract][Full Text] [Related]
25. Ticlopidine, a cholestatic liver injury-inducible drug, causes dysfunction of bile formation via diminished biliary secretion of phospholipids: involvement of biliary-excreted glutathione-conjugated ticlopidine metabolites.
Yoshikado T; Takada T; Yamamoto H; Tan JK; Ito K; Santa T; Suzuki H
Mol Pharmacol; 2013 Feb; 83(2):552-62. PubMed ID: 23220748
[TBL] [Abstract][Full Text] [Related]
26. ABCB4 Gene Aberrations in Human Liver Disease: An Evolving Spectrum.
Reichert MC; Lammert F
Semin Liver Dis; 2018 Nov; 38(4):299-307. PubMed ID: 30357767
[TBL] [Abstract][Full Text] [Related]
27. Sodium 4-phenylbutyrate acts as a chemical chaperone on misfolded myocilin to rescue cells from endoplasmic reticulum stress and apoptosis.
Yam GH; Gaplovska-Kysela K; Zuber C; Roth J
Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1683-90. PubMed ID: 17389500
[TBL] [Abstract][Full Text] [Related]
28. Sequencing of FIC1, BSEP and MDR3 in a large cohort of patients with cholestasis revealed a high number of different genetic variants.
Dröge C; Bonus M; Baumann U; Klindt C; Lainka E; Kathemann S; Brinkert F; Grabhorn E; Pfister ED; Wenning D; Fichtner A; Gotthardt DN; Weiss KH; McKiernan P; Puri RD; Verma IC; Kluge S; Gohlke H; Schmitt L; Kubitz R; Häussinger D; Keitel V
J Hepatol; 2017 Dec; 67(6):1253-1264. PubMed ID: 28733223
[TBL] [Abstract][Full Text] [Related]
29. Stimulation of ABCB4/MDR3 ATPase activity requires an intact phosphatidylcholine lipid.
Prescher M; Smits SHJ; Schmitt L
J Lipid Res; 2020 Dec; 61(12):1605-1616. PubMed ID: 32917728
[TBL] [Abstract][Full Text] [Related]
30. Rescue of a pathogenic mutant human glucagon receptor by pharmacological chaperones.
Yu R; Chen CR; Liu X; Kodra JT
J Mol Endocrinol; 2012 Oct; 49(2):69-78. PubMed ID: 22693263
[TBL] [Abstract][Full Text] [Related]
31. Phosphorylation of ABCB4 impacts its function: insights from disease-causing mutations.
Gautherot J; Delautier D; Maubert MA; Aït-Slimane T; Bolbach G; Delaunay JL; Durand-Schneider AM; Firrincieli D; Barbu V; Chignard N; Housset C; Maurice M; Falguières T
Hepatology; 2014 Aug; 60(2):610-21. PubMed ID: 24723470
[TBL] [Abstract][Full Text] [Related]
32. ABCB4 mediates diet-induced hypercholesterolemia in laboratory opossums.
Chan J; Mahaney MC; Kushwaha RS; VandeBerg JF; VandeBerg JL
J Lipid Res; 2010 Oct; 51(10):2922-8. PubMed ID: 20488799
[TBL] [Abstract][Full Text] [Related]
33. Structures of ABCB4 provide insight into phosphatidylcholine translocation.
Nosol K; Bang-Sørensen R; Irobalieva RN; Erramilli SK; Stieger B; Kossiakoff AA; Locher KP
Proc Natl Acad Sci U S A; 2021 Aug; 118(33):. PubMed ID: 34385322
[TBL] [Abstract][Full Text] [Related]
34. Defective trafficking of nephrin missense mutants rescued by a chemical chaperone.
Liu XL; Doné SC; Yan K; Kilpeläinen P; Pikkarainen T; Tryggvason K
J Am Soc Nephrol; 2004 Jul; 15(7):1731-8. PubMed ID: 15213260
[TBL] [Abstract][Full Text] [Related]
35. Functional Characterization of ABCB4 Mutations Found in Low Phospholipid-Associated Cholelithiasis (LPAC).
Kim TH; Park HJ; Choi JH
Korean J Physiol Pharmacol; 2013 Dec; 17(6):525-30. PubMed ID: 24381502
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological rescue of carnitine transport in primary carnitine deficiency.
Amat di San Filippo C; Pasquali M; Longo N
Hum Mutat; 2006 Jun; 27(6):513-23. PubMed ID: 16652335
[TBL] [Abstract][Full Text] [Related]
37. Thapsigargin or curcumin does not promote maturation of processing mutants of the ABC transporters, CFTR, and P-glycoprotein.
Loo TW; Bartlett MC; Clarke DM
Biochem Biophys Res Commun; 2004 Dec; 325(2):580-5. PubMed ID: 15530432
[TBL] [Abstract][Full Text] [Related]
38. ABCB4 gene mutation-associated cholelithiasis in adults.
Rosmorduc O; Hermelin B; Boelle PY; Parc R; Taboury J; Poupon R
Gastroenterology; 2003 Aug; 125(2):452-9. PubMed ID: 12891548
[TBL] [Abstract][Full Text] [Related]
39. Effects of Chemical Chaperones on Thyroid Hormone Transport by MCT8 Mutants in Patient-Derived Fibroblasts.
Groeneweg S; van den Berge A; Meima ME; Peeters RP; Visser TJ; Visser WE
Endocrinology; 2018 Mar; 159(3):1290-1302. PubMed ID: 29309566
[TBL] [Abstract][Full Text] [Related]
40. Suppressive effects of 4-phenylbutyrate on the aggregation of Pael receptors and endoplasmic reticulum stress.
Kubota K; Niinuma Y; Kaneko M; Okuma Y; Sugai M; Omura T; Uesugi M; Uehara T; Hosoi T; Nomura Y
J Neurochem; 2006 Jun; 97(5):1259-68. PubMed ID: 16539653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
